Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc-Reference-Cited by-同舟云学术

Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc

Published:1997-09 Issue:5 Volume:54 Page:563-573
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Chelliah Jeyananthan,Freemerman Alex J.,Wu-Pong Susanna,Jarvis W.David,Grant Steven

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference57 articles.

1. Function of the c-Myc oncoprotein;Kato;FASEB J,1992

2. Possible function of the c-Myc product: Promotion of cellular DNA replication;Iguchi-Ariga;EMBO J,1987

3. Relationship of c-Myc expression to differentiation and proliferation of HL-60 cells;Filmus;Cancer Res,1985

4. myc Family oncogenes in the development of normal and neoplastic cells;DePinho;Adv Cancer Res,1991

5. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor;Kelly;Cell,1983

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis;Hematology;2010-08

2. Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cells;Blood;2003-05-01

3. Investigational Therapy in Acute Myeloid Leukemia: 2001;Haematology and Blood Transfusion Hämatologie und Bluttransfusion;2003

4. The clinical development of the bryostatins;Anti-Cancer Drugs;2002-08

5. BIOSYNTHETIC PRODUCTS FOR ANTICANCER DRUG DESIGN AND TREATMENT: THE BRYOSTATINS;Anticancer Drug Development;2002